Tenderwize
Wróć do wyszukiwania

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Apr 27, 2028 · 611 days left·Open·Supplies·Framework
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Midazolam (ATC-Code (WHO): N05CD08).

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Midazolam (ATC N05CD08) as pharmaceutical products under a non-exclusive discount agreement for outpatient care in Lower Saxony, Germany.
  • Participation is open to all pharmaceutical entrepreneurs meeting eligibility criteria on a first-come, first-served basis without competitive selection.
Pokaż pełne podsumowanie

This is a non-exclusive discount agreement (open-house model) for Midazolam (ATC N05CD08) as pharmaceutical products for outpatient care in Lower Saxony, Germany, from 01.07.2026 to 30.06.2028. All eligible pharmaceutical entrepreneurs can join at any time (monthly) during the period. No selection is made; the notice is published for transparency. No estimated value is provided.

Ryzyka

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG with respect to the offered medicinal products containing Midazolam.
  • Must have a seat in Germany, another EU member state, or an EEA state (§ 9 Abs. 2 Satz 1 AMG).
  • Local representatives are allowed only if they themselves are pharmaceutical entrepreneurs for the offered products.

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Hannover, DEU

Identyfikator

AOK- Niedersachsen. Die Gesundheitskasse

Działalność

Health

Części (1)

LOT-0000

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

Conclusion of a non-exclusive discount agreement according to § 130a Abs. 8 SGB V for the active ingredient Midazolam (ATC code: N05CD08) for outpatient care in Lower Saxony. Open-house model: no selection, all eligible pharmaceutical entrepreneurs can join. Contract duration: 01.07.2026 to 30.06.2028, with possible monthly joining and 6-week notice termination.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE929, Germany

Czas trwania

Jun 2026 - Jun 2028

Kategoria

Pharmaceutical products

Termin

Deadline Apr 27, 2028

Szczegóły zamówienia

Data publikacji
14 May 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
332947-2026

Podobne przetargi